title: EBUS-guided mediastinal lung cancer staging: monitoring of quality standards improves performance.
abstract: This audit examined key performance indices related to endobronchial ultrasound (EBUS)-guided mediastinal lung cancer staging before and after the introduction of defined quality standards, at four independent EBUS centres in one cancer network. Data from 642 procedures were prospectively collected and analysed. The introduction of standards was associated with a significant increase (p<0.001) in sampling of key mediastinal lymph node stations (4R, 4L and 7) and a reduction in the variability of staging sensitivity between centres. These data reinforce the requirement for an appropriate regulatory framework for EBUS-transbronchial needle aspiration provision that includes quality assurance and performance monitoring.
authors.affiliation: Manchester Thoracic Oncology Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK The Institute of Inflammation and Repair, The University of Manchester, Manchester, UK.
authors.forename: Matthew
authors.initials: M
authors.lastname: Evison
authors.affiliation: Manchester Thoracic Oncology Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK The Institute of Inflammation and Repair, The University of Manchester, Manchester, UK.
authors.forename: Philip
authors.initials: P
authors.lastname: Crosbie
authors.affiliation: Manchester Thoracic Oncology Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK.
authors.forename: Julie
authors.initials: J
authors.lastname: Martin
authors.affiliation: Department of Thoracic Surgery, University Hospital South Manchester, Manchester, UK.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Shah
authors.affiliation: Department of Pathology, University Hospital South Manchester, Manchester, UK.
authors.forename: Helen
authors.initials: H
authors.lastname: Doran
authors.affiliation: Department of Respiratory Medicine, North Manchester General Hospital, Pennine Acute NHS Trusts, Manchester, UK.
authors.forename: Zoe
authors.initials: Z
authors.lastname: Borrill
authors.affiliation: Department of Respiratory Medicine, North Manchester General Hospital, Pennine Acute NHS Trusts, Manchester, UK.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Hoyle
authors.affiliation: Department of Cytopathology, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
authors.forename: Durgesh
authors.initials: D
authors.lastname: Rana
authors.affiliation: Department of Respiratory Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Bailey
authors.affiliation: Manchester Thoracic Oncology Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK The Institute of Inflammation and Repair, The University of Manchester, Manchester, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Booton
mesh_terms: D001999:Bronchoscopy / Q000379:methods; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis / Q000473:pathology*; D061765:Endoscopic Ultrasound-Guided Fine Needle Aspiration / Q000592:standards; D004739:England; D006801:Humans; D008479:Mediastinal Neoplasms / Q000175:diagnosis / Q000473:pathology*; D008485:Medical Audit; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011446:Prospective Studies; D012680:Sensitivity and Specificity
keywords: Bronchoscopy; Lung Cancer; Non-Small Cell Lung Cancer; Thoracic Surgery